肝脏供体中利多卡因代谢物的形成作为预测受者安全有效引入环孢素的一项检测。 - Suppr | 超能文献

Lidocaine metabolite formation in the liver donor as a predictive test for the safe and efficient introduction of cyclosporine in the recipient.

作者信息

Azoulay D, Lemoine A, Gries J M, Adam R, Dolizy I, Fredj G, Beaune P, Bismuth H

机构信息

Hepatobiliary Surgery and Liver Transplant Research Unit, Paul Brousse Hospital, Villejuif, France.

出版信息

Transplant Proc. 1993 Jun;25(3):2275-8.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Lidocaine metabolite formation in the liver donor as a predictive test for the safe and efficient introduction of cyclosporine in the recipient.肝脏供体中利多卡因代谢物的形成作为预测受者安全有效引入环孢素的一项检测。

Transplant Proc. 1993 Jun;25(3):2275-8.

2

Histological comparison of donor livers and lidocaine metabolism in the utilization of organs for liver transplantation.肝移植供肝的组织学比较及利多卡因代谢在肝移植器官利用中的研究

Transplant Proc. 1993 Feb;25(1 Pt 2):1662-3.

3

Metabolic liver function and lipoprotein metabolism after orthotopic liver transplantation in patients on immunosuppressive therapy with FK 506 or cyclosporine.

Transplant Proc. 1995 Feb;27(1):1201-3.

4

Acute cyclosporine toxicity after liver transplantation is predicted by the lidocaine monoethylglycinexylidide test in the donor.供体利多卡因单乙基甘氨酰二甲苯胺试验可预测肝移植后急性环孢素毒性。

Liver Transpl Surg. 1997 Sep;3(5):526-31. doi: 10.1002/lt.500030508.

5

Lidocaine metabolism as an index of liver function in hepatic transplant donors and recipients.利多卡因代谢作为肝移植供体和受体肝功能的一项指标

Transplant Proc. 1989 Feb;21(1 Pt 2):2299-301.

6

The value of the donor MEGX test in predicting liver allograft recipient outcome.供体MEGX试验在预测肝移植受者预后中的价值。

Transplantation. 1994 Aug 27;58(4):524-6. doi: 10.1097/00007890-199408270-00023.

7

Lignocaine metabolite formation as a measure of pre-transplant liver function.利多卡因代谢物的形成作为移植前肝功能的一项指标。

Lancet. 1989 Mar 25;1(8639):640-2. doi: 10.1016/s0140-6736(89)92144-2.

8

Donor rating in human liver transplantation: correlation of oxygen consumption after revascularization with MEGX formation in donors.人类肝移植中的供体评级：供体血管再通后氧消耗与MEGX形成的相关性。

Transplant Proc. 1989 Feb;21(1 Pt 2):2392-3.

9

Limits of the MEGX test in the selection of liver grafts for transplantation.MEGX试验在肝移植供肝选择中的局限性。

Transplant Proc. 1993 Feb;25(1 Pt 2):1653-4.

10

MEGX as a test of donor liver function.MEGX作为供体肝功能的一项检测

Transplant Proc. 1992 Oct;24(5):1960-1.

引用本文的文献

1

The lignocaine metabolite (MEGX) liver function test and P-450 induction in humans.利多卡因代谢物（MEGX）肝功能试验及人体中的细胞色素P-450诱导作用。

Br J Clin Pharmacol. 1998 Dec;46(6):535-9. doi: 10.1046/j.1365-2125.1998.00829.x.